# Valsartan/Hydrochlorothiazide Combination in the Treatment of Severe Hypertension

> **NCT00273299** · PHASE3 · COMPLETED · sponsor: **Novartis** · enrollment: 607 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** valsartan plus hydrochlorothiazide

## Key facts

- **NCT ID:** NCT00273299
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11
- **Primary completion:** 2006-07
- **Final completion:** 2006-07
- **Target enrollment:** 607 (ACTUAL)
- **Last updated:** 2011-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00273299

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00273299, "Valsartan/Hydrochlorothiazide Combination in the Treatment of Severe Hypertension". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00273299. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*